Editorial
doi: 10.1016/j.jcf.2014.01.003.
Epub 2014 Jan 30.
At last, Burkholderia spp. is one of the inclusion criteria--a negative (but published) randomised controlled trial
Affiliations
- PMID: 24485846
- DOI: 10.1016/j.jcf.2014.01.003
Item in Clipboard
Editorial
At last, Burkholderia spp. is one of the inclusion criteria--a negative (but published) randomised controlled trial
J Cyst Fibros.
2014 May.
Free article
No abstract available
Comment on
-
Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: a placebo-controlled trial.J Cyst Fibros. 2014 May;13(3):296-305. doi: 10.1016/j.jcf.2013.08.011. Epub 2013 Oct 28. J Cyst Fibros. 2014. PMID: 24176390 Clinical Trial.
Similar articles
-
Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: a placebo-controlled trial.J Cyst Fibros. 2014 May;13(3):296-305. doi: 10.1016/j.jcf.2013.08.011. Epub 2013 Oct 28. J Cyst Fibros. 2014. PMID: 24176390 Clinical Trial.
-
Successful treatment of resistant Burkholderia multivorans infection in a patient with cystic fibrosis using ceftazidime/avibactam plus aztreonam.J Antimicrob Chemother. 2018 Aug 1;73(8):2270-2271. doi: 10.1093/jac/dky136. J Antimicrob Chemother. 2018. PMID: 29912407 No abstract available.
-
Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?J Cyst Fibros. 2010 Jan;9(1):73-4. doi: 10.1016/j.jcf.2009.11.001. Epub 2009 Nov 22. J Cyst Fibros. 2010. PMID: 19932062 Clinical Trial. No abstract available.
-
Inhaled aztreonam lysine for cystic fibrosis pulmonary disease-related outcomes.Ann Pharmacother. 2012 Jul-Aug;46(7-8):1076-85. doi: 10.1345/aph.1Q653. Epub 2012 Jul 3. Ann Pharmacother. 2012. PMID: 22764322 Review.
-
Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis.Ther Adv Respir Dis. 2015 Feb;9(1):16-21. doi: 10.1177/1753465814561624. Ther Adv Respir Dis. 2015. PMID: 25471692 Review.
Cited by
-
Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.Cochrane Database Syst Rev. 2019 Jun 13;6(6):CD013079. doi: 10.1002/14651858.CD013079.pub2. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2021 Dec 10;12:CD013079. doi: 10.1002/14651858.CD013079.pub3. PMID: 31194880 Free PMC article. Updated.
-
Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.Cochrane Database Syst Rev. 2020 Apr 2;4(4):CD009529. doi: 10.1002/14651858.CD009529.pub4. Cochrane Database Syst Rev. 2020. PMID: 32239690 Free PMC article.
-
Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosis.Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD009876. doi: 10.1002/14651858.CD009876.pub4. Cochrane Database Syst Rev. 2019. PMID: 30997925 Free PMC article.
-
Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.Cochrane Database Syst Rev. 2018 Oct 30;10(10):CD008319. doi: 10.1002/14651858.CD008319.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Aug 1;8:CD008319. doi: 10.1002/14651858.CD008319.pub4. PMID: 30376155 Free PMC article. Updated.
-
Garlic revisited: antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex.PLoS One. 2014 Dec 1;9(12):e112726. doi: 10.1371/journal.pone.0112726. eCollection 2014. PLoS One. 2014. PMID: 25438250 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
